bisoprolol has been researched along with Leishmaniasis in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, I | 1 |
| Levin, MJ | 1 |
| Wallukat, G | 1 |
| Elies, R | 1 |
| Lebesgue, D | 1 |
| Chiale, P | 1 |
| Elizari, M | 1 |
| Rosenbaum, M | 1 |
| Hoebeke, J | 1 |
1 other study available for bisoprolol and Leishmaniasis
| Article | Year |
|---|---|
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.
Topics: Amino Acid Sequence; Animals; Animals, Newborn; Antibodies, Protozoan; Antigens, Protozoan; Autoanti | 1995 |